Geneticure is a personalized medicine company with patented tests that control chronic diseases faster than trial/error, with less cost
Geneticure is a Mayo Clinic backed company that has created a patented cheek-swab test that can predict individual treatment response for high blood pressure medications and devices therapies.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 1, 2022 | Seed | $1.68M | — | — | — | Detail |
Dec 31, 2019 | Seed | $1M | — | — | — | Detail |
Apr 1, 2018 | Seed | $1.36M | 1 | — | — | Detail |
Sep 1, 2017 | Seed | $850K | 1 | Wireframe Ventures | — | Detail |
Apr 5, 2017 | Seed | $200K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Wireframe Ventures | Yes | Seed |
Fairview Health Services | Yes | Pre-seed |
Mayo Clinic Ventures | — | Seed |
M25 | — | Seed |